10x Genomics, Inc.
US ˙ NasdaqGS ˙ US88025U1097

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for McAnear Justin J.. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at McAnear Justin J. har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:TXG / 10x Genomics, Inc. 143 242
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av McAnear Justin J.. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp TXG / 10x Genomics, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i TXG / 10x Genomics, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
2022-05-13 TXG McAnear Justin J. 158 40,4855 158 40,4855 6 397 322 55.7900 2 419 37,82

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

TXG / 10x Genomics, Inc. Insider Trades
Internhandel TXG / 10x Genomics, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i TXG / 10x Genomics, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
2024-08-22 TXG McAnear Justin J. 2 961 22,5297 2 961 22,5297 66 710 229 7.1400 −45 568 −68,31
2024-05-22 TXG McAnear Justin J. 2 936 24,3036 2 936 24,3036 71 355
2024-02-22 TXG McAnear Justin J. 1 865 46,3443 1 865 46,3443 86 432
2023-11-22 TXG McAnear Justin J. 1 679 43,3367 1 679 43,3367 72 762
2023-08-22 TXG McAnear Justin J. 1 678 45,7811 1 678 45,7811 76 821
2023-05-23 TXG McAnear Justin J. 194 55,0695 194 55,0695 10 683
2023-05-23 TXG McAnear Justin J. 465 55,0621 465 55,0621 25 604
2023-05-23 TXG McAnear Justin J. 441 55,0641 441 55,0641 24 283
2023-05-23 TXG McAnear Justin J. 565 55,0637 565 55,0637 31 111
2023-02-22 TXG McAnear Justin J. 1 245 47,7533 1 245 47,7533 59 453
2022-11-22 TXG McAnear Justin J. 686 34,0651 686 34,0651 23 369
2022-11-22 TXG McAnear Justin J. 652 34,0679 652 34,0679 22 212
2022-11-22 TXG McAnear Justin J. 288 34,0665 288 34,0665 9 811
2022-08-23 TXG McAnear Justin J. 987 35,1913 987 35,1913 34 734
2022-05-23 TXG McAnear Justin J. 967 48,7641 967 48,7641 47 155
2022-02-22 TXG McAnear Justin J. 288 78,5994 288 78,5994 22 637
2021-11-22 TXG McAnear Justin J. 281 148,3811 281 148,3811 41 695
2021-08-23 TXG McAnear Justin J. 270 161,8475 270 161,8475 43 699
2021-05-24 TXG McAnear Justin J. 281 162,6596 281 162,6596 45 707

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

TXG / 10x Genomics, Inc. Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av McAnear Justin J. som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2024-08-26 2024-08-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −2 961 143 242 −2,03 22,53 −66 710 3 227 199
2024-05-23 2024-05-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −2 936 146 203 −1,97 24,30 −71 355 3 553 259
2024-03-25 2024-03-21 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 53 312 148 552 55,98
2024-02-26 2024-02-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −1 865 95 240 −1,92 46,34 −86 432 4 413 831
2023-11-27 2023-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −1 679 97 105 −1,70 43,34 −72 762 4 208 210
2023-08-24 2023-08-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −1 678 98 784 −1,67 45,78 −76 821 4 522 440
2023-05-25 2023-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −565 100 462 −0,56 55,06 −31 111 5 531 809
2023-05-25 2023-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −441 101 027 −0,43 55,06 −24 283 5 562 961
2023-05-25 2023-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −465 101 468 −0,46 55,06 −25 604 5 587 041
2023-05-25 2023-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −194 101 933 −0,19 55,07 −10 683 5 613 399
2023-03-23 2023-03-21 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 25 991 101 510 34,42
2023-02-24 2023-02-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −1 245 75 519 −1,62 47,75 −59 453 3 606 281
2022-11-23 2022-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −288 76 764 −0,37 34,07 −9 811 2 615 081
2022-11-23 2022-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −652 77 052 −0,84 34,07 −22 212 2 625 000
2022-11-23 2022-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −686 77 704 −0,88 34,07 −23 369 2 646 995
2022-09-16 2022-09-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 20 297 78 389 34,94
2022-08-25 2022-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −987 58 092 −1,67 35,19 −34 734 2 044 333
2022-05-25 2022-05-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −967 59 079 −1,61 48,76 −47 155 2 880 934
2022-05-17 2022-05-13 4 TXG 10x Genomics, Inc.
Class A Common Stock
P - Purchase 158 60 046 0,26 40,49 6 397 2 430 992
2022-03-24 2022-03-22 4 TXG 10x Genomics, Inc.
Stock Option (Right to Buy)
A - Award 53 392 53 392
2022-03-24 2022-03-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 21 357 59 888 55,43
2022-02-24 2022-02-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −288 38 531 −0,74 78,60 −22 637 3 028 513
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 350 159 −2,78
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 38 819 −1,27 149,18 −74 589 5 790 941
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 39 319 −1,26 148,04 −74 022 5 820 942
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 334 39 819 −3,24 146,92 −195 988 5 850 120
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 083 41 153 −9,03 145,96 −595 937 6 006 511
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −3 583 45 236 −7,34 145,16 −520 115 6 566 544
2022-01-05 2022-01-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 48 819 25,76 5,04 50 400 246 048
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 360 159 −2,70
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 38 819 −0,26 155,55 −15 555 6 038 295
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 38 919 −0,51 153,86 −30 772 5 987 984
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 39 119 −0,76 151,80 −45 539 5 938 135
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 39 419 −0,76 151,31 −45 394 5 964 674
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 39 719 −1,24 150,71 −75 357 5 986 209
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −600 40 219 −1,47 149,40 −89 643 6 008 920
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 302 40 819 −3,09 148,48 −193 321 6 060 805
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 700 42 121 −6,02 147,62 −398 563 6 217 725
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 536 44 821 −3,31 146,49 −225 014 6 565 994
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 462 46 357 −5,04 145,54 −358 323 6 746 867
2021-12-03 2021-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 48 819 25,76 5,04 50 400 246 048
2021-11-24 2021-11-22 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −281 38 819 −0,72 148,38 −41 695 5 760 006
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 370 159 −2,63
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 39 100 −0,51 164,96 −32 992 6 450 014
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 333 39 300 −9,93 164,05 −710 847 6 447 330
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 667 43 633 −9,66 163,34 −762 314 7 127 075
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 48 300 −1,02 162,16 −81 079 7 832 217
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 48 800 −0,61 160,48 −48 142 7 831 180
2021-11-03 2021-11-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 49 100 25,58 5,04 50 400 247 464
2021-10-05 2021-10-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 380 159 −2,56
2021-10-05 2021-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 200 39 100 −2,98 144,57 −173 485 5 652 718
2021-10-05 2021-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 666 40 300 −12,33 143,79 −814 725 5 794 814
2021-10-05 2021-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 500 45 966 −5,16 142,80 −357 008 6 564 087
2021-10-05 2021-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −634 48 466 −1,29 141,96 −90 003 6 880 282
2021-10-05 2021-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 49 100 25,58 5,04 50 400 247 464
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 390 159 −2,50
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 540 39 100 −3,79 178,80 −275 358 6 991 240
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 747 40 640 −10,46 177,87 −844 359 7 228 726
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 200 45 387 −4,62 177,00 −389 396 8 033 417
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 139 47 587 −2,34 175,95 −200 412 8 373 133
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −374 48 726 −0,76 174,87 −65 401 8 520 716
2021-09-03 2021-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 49 100 25,58 5,04 50 400 247 464
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −270 39 100 −0,69 161,85 −43 699 6 328 237
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 400 159 −2,44
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 39 370 −0,76 184,52 −55 357 7 264 682
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 39 670 −1,24 183,30 −91 650 7 271 511
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −700 40 170 −1,71 182,16 −127 514 7 317 484
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 302 40 870 −5,33 181,31 −417 376 7 410 144
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 298 43 172 −5,05 180,29 −414 304 7 783 437
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 202 45 470 −4,62 179,28 −394 780 8 151 975
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 698 47 672 −3,44 178,35 −302 840 8 502 344
2021-08-04 2021-08-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 49 370 25,40 5,04 50 400 248 825
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 410 159 −2,38
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 39 370 −0,25 195,82 −19 582 7 709 433
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −700 39 470 −1,74 194,81 −136 364 7 688 969
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 400 40 170 −3,37 193,76 −271 268 7 783 456
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −800 41 570 −1,89 192,95 −154 358 8 020 819
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 500 42 370 −3,42 191,73 −287 602 8 123 799
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 800 43 870 −6,00 190,66 −533 859 8 364 421
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 700 46 670 −5,47 189,85 −512 601 8 860 402
2021-07-06 2021-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 49 370 25,40 5,04 50 400 248 825
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 420 159 −2,32
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 39 011 −0,76 180,02 −54 007 7 022 889
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 39 311 −0,51 179,21 −35 842 7 044 826
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 39 511 −0,75 178,07 −53 420 7 035 593
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 906 39 811 −6,80 175,77 −510 786 6 997 560
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 994 42 717 −4,46 174,93 −348 808 7 472 425
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 000 44 711 −2,19 173,94 −173 944 7 777 210
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −800 45 711 −1,72 172,85 −138 279 7 901 064
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 500 46 511 −5,10 171,59 −428 984 7 980 999
2021-06-03 2021-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 49 011 25,63 5,04 50 400 247 015
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale −281 39 011 −0,72 162,66 −45 707 6 345 514
2021-05-26 2021-03-19 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 22 338 22 338
2021-05-26 2021-03-19 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 8 935 39 292 29,43
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 430 159 −2,27
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 30 357 −0,33 198,09 −19 809 6 013 418
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 30 457 −0,65 194,92 −38 984 5 936 678
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −794 30 657 −2,52 193,40 −153 560 5 929 067
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −3 706 31 451 −10,54 192,46 −713 241 6 052 927
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 700 35 157 −7,13 191,77 −517 783 6 742 114
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 900 37 857 −4,78 190,63 −362 191 7 216 563
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −600 39 757 −1,49 189,57 −113 743 7 536 806
2021-05-05 2021-05-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 40 357 32,94 5,04 50 400 203 399
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 440 159 −2,22
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 800 30 357 −5,60 185,76 −334 361 5 638 998
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −3 795 32 157 −10,56 185,02 −702 152 5 949 698
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −3 205 35 952 −8,18 184,12 −590 096 6 619 382
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −700 39 157 −1,76 183,19 −128 231 7 173 057
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 39 857 −0,50 181,82 −36 365 7 246 999
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 40 057 −0,74 180,02 −54 007 7 211 193
2021-04-02 2021-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 40 357 32,94 5,04 50 400 203 399
2021-03-10 2021-03-10 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise −9 583 10 417 −47,92
2021-03-10 2021-03-10 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 9 583 30 357 46,13 11,48 110 013 348 498
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 450 159 −2,17
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 20 774 −0,48 154,82 −15 482 3 216 231
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −300 20 874 −1,42 154,14 −46 241 3 217 449
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −400 21 174 −1,85 152,08 −60 833 3 220 195
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −800 21 574 −3,58 151,22 −120 977 3 262 448
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 200 22 374 −5,09 150,22 −180 261 3 360 966
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 100 23 574 −4,46 149,43 −164 371 3 522 620
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 24 674 −0,80 148,08 −29 616 3 653 726
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 476 24 874 −5,60 146,88 −216 793 3 653 453
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 902 26 350 −6,73 145,90 −277 501 3 844 460
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 100 28 252 −3,75 145,03 −159 528 4 097 260
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −400 29 352 −1,34 142,48 −56 994 4 182 220
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 022 29 752 −3,32 141,25 −144 357 4 202 467
2021-03-10 2021-03-08 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 30 774 48,14 5,04 50 400 155 101
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 460 159 −2,13
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 20 774 −2,35 178,49 −89 247 3 708 034
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −910 21 274 −4,10 177,50 −161 525 3 776 139
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 777 22 184 −11,13 176,51 −490 171 3 915 718
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 213 24 961 −17,28 175,53 −915 027 4 381 352
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −600 30 174 −1,95 174,18 −104 509 5 255 759
2021-02-03 2021-02-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 30 774 48,14 5,04 50 400 155 101
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 470 159 −2,08
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 20 774 −0,95 141,91 −28 382 2 948 038
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 764 20 974 −7,76 140,78 −248 331 2 952 659
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −6 036 22 738 −20,98 139,91 −844 525 3 181 380
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 000 28 774 −6,50 139,08 −278 152 4 001 776
2021-01-06 2021-01-04 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 30 774 48,14 5,04 50 400 155 101
2020-12-28 2020-12-23 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise −19 841 480 159 −3,97
2020-12-28 2020-12-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 19 841 20 774 2 126,58 5,04 99 999 104 701
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 500 000 −1,96
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 933 −34,89 153,79 −76 897 143 490
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 108 1 433 −59,53 153,21 −322 965 219 549
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 600 3 541 −31,12 151,80 −242 883 537 531
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −3 168 5 141 −38,13 150,94 −478 186 775 995
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 624 8 309 −24,00 150,03 −393 680 1 246 604
2020-12-03 2020-12-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 933 1 071,81 5,04 50 400 55 102
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −2 900 510 000 −0,57
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 933 −9,68 138,73 −13 873 129 435
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 600 1 033 −60,77 137,57 −220 119 142 114
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 000 2 633 −27,53 136,54 −136 544 359 520
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 3 633 −5,22 135,55 −27 110 492 453
2020-11-04 2020-11-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 2 900 3 833 310,83 5,04 14 616 19 318
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −7 100 512 900 −1,37
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −400 933 −30,01 139,21 −55 684 129 883
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 1 333 −27,28 137,99 −68 995 183 941
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −500 1 833 −21,43 137,10 −68 552 251 312
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 376 2 333 −65,23 136,10 −595 581 317 525
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 324 6 709 −16,48 135,40 −179 264 908 370
2020-11-04 2020-11-02 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 7 100 8 033 760,99 5,04 35 784 40 486
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 520 000 −1,89
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 933 −9,68 126,88 −12 688 118 379
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 988 1 033 −74,31 125,98 −376 419 130 134
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 612 4 021 −58,26 125,48 −704 219 504 573
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 300 9 633 −11,89 124,19 −161 448 1 196 330
2020-10-05 2020-10-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 933 1 071,81 5,04 50 400 55 102
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 530 000 −1,85
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −215 933 −18,73 115,52 −24 837 107 780
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 684 1 148 −70,04 114,78 −308 078 131 771
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 201 3 832 −57,58 113,83 −592 045 436 208
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 900 9 033 −17,38 112,91 −214 527 1 019 904
2020-09-03 2020-09-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 933 1 071,81 5,04 50 400 55 102
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 540 000 −1,82
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −800 933 −46,16 100,76 −80 610 94 011
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −6 348 1 733 −78,55 99,39 −630 904 172 236
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 852 8 081 −26,09 98,85 −281 916 798 796
2020-08-05 2020-08-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 933 1 071,81 5,04 50 400 55 102
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 550 000 −1,79
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −100 0 −100,00 88,63 −8 863
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 779 100 −97,95 88,03 −420 695 8 803
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 121 4 879 −51,21 87,18 −446 439 425 342
2020-07-02 2020-07-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 000 5,04 50 400 50 400
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 560 000 −1,75
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 800 0 −100,00 81,84 −147 321
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 200 1 800 −55,00 81,27 −178 797 146 289
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 600 4 000 −28,57 80,02 −128 029 320 072
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 400 5 600 −20,00 79,08 −110 714 442 856
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 100 7 000 −23,08 78,00 −163 804 546 012
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −900 9 100 −9,00 77,09 −69 378 701 494
2020-06-03 2020-06-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 000 5,04 50 400 50 400
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 570 000 −1,72
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 600 0 −100,00 78,70 −204 631
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 010 2 600 −43,60 77,66 −156 097 201 917
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 390 4 610 −53,90 76,64 −413 110 353 327
2020-05-05 2020-05-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 000 5,04 50 400 50 400
2020-04-23 2020-04-21 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 90 667 90 667
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 580 000 −1,69
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −200 0 −100,00 59,82 −11 964
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −5 110 200 −96,23 58,32 −298 025 11 664
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −4 690 5 310 −46,90 57,76 −270 889 306 699
2020-04-03 2020-04-01 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 000 5,04 50 400 50 400
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise X −10 000 590 000 −1,67
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 225 0 −100,00 69,68 −85 359
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −900 1 225 −42,35 68,26 −61 432 83 616
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −600 2 125 −22,02 66,74 −40 047 141 833
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −700 2 725 −20,44 65,72 −46 002 179 079
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 940 3 425 −36,16 64,58 −125 280 221 178
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −2 835 5 365 −34,57 63,65 −180 439 341 465
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X −1 800 8 200 −18,00 62,77 −112 993 514 746
2020-03-09 2020-03-06 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise X 10 000 10 000 5,04 50 400 50 400
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 20 000 20 000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other −20 000 0 −100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 600 000 600 000
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other −600 000 0 −100,00
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)